Mirhan N Makled

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Ulcerative Colitis

Anti Inflammatory

Top Venues

Journal of biochemical and molecular toxicology

Basic & clinical pharmacology & toxicology

Fundamental & clinical pharmacology

Human & experimental toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Mirhan N Makled, Ahmed R El-Sheakh
Fingolimod attenuates ovalbumin-induced airway inflammation via inhibiting MAPK/ERK signaling in mice. Journal of biochemical and molecular toxicology (2022)
Mirhan N Makled, Marwa S Serrya, Ahmed R El-Sheakh
Fingolimod ameliorates acetic acid-induced ulcerative colitis: An insight into its modulatory impact on pro/anti-inflammatory cytokines and AKT/mTOR signalling. Basic & clinical pharmacology & toxicology 130 (5) (2022)
Mirhan N Makled, Mohammed S El-Awady, Rania R Abdelaziz, Ahmed B Shehab El-Din, Elsayed M Ammar, Nariman M Gameil
Pomegranate extract ameliorates renal ischemia/reperfusion injury in rats via suppressing NF-κB pathway. Human & experimental toxicology 40 (12_suppl) (2021)
Maha H Sharawy, Mohammed S El-Awady, Mirhan N Makled
Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model. Journal of biochemical and molecular toxicology 35 (5) (2021)
Mirhan N Makled, Eman Said
Tranilast abrogates cisplatin-induced testicular and epididymal injuries: An insight into its modulatory impact on apoptosis/proliferation. Journal of biochemical and molecular toxicology 35 (8) (2021)
Dana A Sherif, Mirhan N Makled, Ghada M Suddek
The HIV reverse transcriptase Inhibitor Tenofovir suppressed DMH/HFD-induced colorectal cancer in Wistar rats. Fundamental & clinical pharmacology 35 (6) (2021)